thiolactomycin

Subscribe to Selected New Research on thiolactomycin

8 relevant articles (0 outcomes, 1 trials/studies) found for this Bio-Agent

Description: from actinomycetes; structure given in first source

Also Known As:

2(5H)-Thiophenone, 4-hydroxy-3,5-dimethyl-5-(2-methyl-1,3-butadienyl)-, (S-(E))-

Bio-Agent Context: Research Results

Organic Chemicals: 40

Sulfur Compounds: 82

Thiophenes: 10

thiolactomycin: 8

Heterocyclic Compounds: 23

1-Ring Heterocyclic Compounds

Thiophenes: 10

thiolactomycin: 8

Related Diseases

1.	Obesity 02/24/2005 - "These studies identify thiolactomycin as a promising template for the development of new selective cancer and obesity treatments." Get all the results and reference details, order at left...
2.	Neoplasms (Cancer) 02/24/2005 - "These studies identify thiolactomycin as a promising template for the development of new selective cancer and obesity treatments." Get all the results and reference details, order at left...
3.	Tuberculosis 01/01/2006 - "Thiolactomycin, a clinical candidate for treatment of tuberculosis has led to further explorations in this class" 11/03/2003 - "tuberculosis mycolic acid biosynthesis, compared to thiolactomycin." 10/01/2002 - "tuberculosis strains with multicopy inhA or kasAB plasmids, were tested for their resistance to INH, ethionamide (ETH) or thiolactomycin (TLM)" 09/01/2003 - "tuberculosis to treatment with the mycolic acid biosynthesis inhibitors isoniazid, thiolactomycin, and triclosan" Get all the results and reference details, order at left...
4.	Malaria 02/15/2004 - "A series of analogues of the naturally occurring antibiotic thiolactomycin (TLM) have been synthesised and evaluated for their ability to inhibit the growth of the malaria parasite, Plasmodium falciparum" 09/22/2005 - "Analogues of the natural antibiotic thiolactomycin (TLM), an inhibitor of the condensing reactions of type II fatty acid synthase, were synthesized and evaluated for their ability to inhibit the growth of the malaria parasite Plasmodium falciparum" Get all the results and reference details, order at left...
5.	Periodontal Diseases (Periodontal Disease) 12/01/1990 - "Antimicrobial activities of thiolactomycin against gram-negative anaerobes associated with periodontal disease" Get all the results and reference details, order at left...
5 Diseases and 8 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Mycolic Acids (Mycolic Acid)
2.	Triclosan (pHisoHex)
3.	Isoniazid (Ftivazide)
4.	Fatty Acid Synthetase Complex (Fatty Acid Synthase)
5.	Ethionamide (Trecator-SC)
5 Drugs and Important Bio-Agents and 4 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>